Glitazones in the treatment of type 2 diabetes (Review of TA9 and TA21)

NICE technology appraisals [TA63] Published date:

Important information about this appraisal

Important information about this appraisal

This appraisal has been updated and replaced by Type 2 diabetes (NICE clinical guideline 66 [partially updated by CG87]).

Get involved